Drug research
20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)NCT06999902 | Praxis Precision Medicines | Phase 2, Phase 3 | Completed | 2026-05-14Actual |
Regulatory dates and decisions
| No regulatory events published here yet.Events appear after automated checks of their supporting sources. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |